GNFEI Technology Co., Ltd Introduces Advanced SPOT-A4-PRO UV Printer for Precision Cylinder and Flatbed Printing

GNFEI Technology Co., Ltd announces the launch of its innovative SPOT-A4-PRO A4 UV printer, engineered for high-quality, versatile printing on both cylindrical and flat surfaces, empowering businesses with enhanced customization capabilities.

GNFEI Technology Co., Ltd., a leader in advanced inkjet printing solutions, today unveiled its latest innovation, the SPOT-A4-PRO A4 UV printer. This cutting-edge machine is designed to meet the growing demand for versatile and high-precision printing on a wide array of substrates, including challenging cylindrical objects. The SPOT-A4-PRO represents a significant step forward in compact printing technology, offering businesses of all sizes the ability to expand their product customization services and explore new market opportunities with vibrant, durable, and detailed prints.

GNFEI Technology Co., Ltd

The newly launched SPOT-A4-PRO is a powerful UV printer that excels in direct-to-object printing. Its advanced LED UV curing system ensures instant ink drying, resulting in sharp, high-resolution images and text on materials such as plastic, glass, metal, wood, and acrylic. Specifically engineered for adaptability, this A4 model includes a robust mechanism for handling both flat items and cylindrical products like bottles, tubes, and cups. This dual capability makes it an ideal solution for businesses producing promotional items, personalized gifts, and bespoke industrial components, offering exceptional print quality and adhesion.

Further enhancing its versatility, the SPOT-A4-PRO functions effectively as a UV DTF printer when used with A/B films. This process allows for the creation of high-quality transfer stickers that can be applied to a multitude of surfaces, including those that are irregular or difficult to print on directly. The UV DTF capability opens up new avenues for product decoration, enabling vibrant, full-color designs with excellent durability and scratch resistance. This feature is particularly beneficial for intricate designs on items where direct printing might be challenging, providing flexibility and superior aesthetic results.

As a comprehensive UV printing machine, the SPOT-A4-PRO is built for efficiency and ease of use. Its compact footprint makes it suitable for various work environments, from small workshops to larger production facilities. The machine supports intuitive software for seamless design integration and print management, allowing users to quickly transition from concept to finished product. GNFEI’s commitment to robust engineering ensures reliability and consistent performance, empowering businesses to meet tight deadlines and deliver high-quality customized products to their clients with confidence and precision.

GNFEI Technology Co., Ltd is confident that the SPOT-A4-PRO A4 UV printer will set a new benchmark in the compact digital printing sector. By combining direct-to-object UV printing with UV DTF capabilities, this machine offers unparalleled flexibility and quality. It empowers users to unlock creative potential and cater to diverse customer demands for personalized and uniquely branded items. This launch underscores GNFEI’s dedication to innovation and providing its global clientele with state-of-the-art printing solutions that drive growth and efficiency in an evolving market.

About GNFEI Technology Co., Ltd.

GNFEI Technology Co., Ltd is a pioneering enterprise in advanced inkjet printing solutions, known for developing and manufacturing high-performance printers for diverse applications, including UV, DTF, and DTG technologies, serving a global market for over a decade.

Media Contact
Company Name: GNFEI Technology Co., Ltd
Contact Person: William
Email: Send Email
Phone: +852-57495795
State: Hong Kong
Country: China
Website: http://www.gnfei.com

Brenmiller Energy: A Thermal Energy Storage Play Hiding in Plain Sight ($BNRG)

As part of our ongoing coverage of the thermal energy storage (TES) sector, we again turn our focus to Brenmiller Energy (NASDAQ: BNRG). Not because we’re repeating ourselves—but because the market still hasn’t caught up to the reality.

In a space dominated by concept-stage ventures and flashy presentations, Brenmiller stands alone as the only pure-play publicly traded TES provider delivering results now. Not projections. Not prototypes. Fully-deployed, sovereign-backed commercial systems already reshaping how industrial energy is stored, distributed, and decarbonized.

And if you think no one’s watching TES—think again.

Speculative capital has flooded into private companies like Rondo Energy, currently valued at over $500 million, despite having only a handful of commercial deployments. While they report further tests underway, returns for deep-pocketed backers remain a question mark.

Following Brenmillers Lead

That’s not a knock on Rondo. Their tech might prove useful. However, there is little public validation to point to yet. Even Brenmiller acknowledges it will take a consortium of TES players to meet what could become a trillion-dollar market over the next decade. Everyone should be rooting for success across the board.

But let’s not ignore the obvious. Brenmiller Energy is the brand delivering TES today.

What makes this especially compelling is that Brenmiller has real traction. Its upcoming Tempo Beverage milestone (expected this July), a €7 million commitment from the European Hydrogen Bank as part of the €25 million SolWinHy Cádiz project, and over $40 million in deployed infrastructure all point to a company firing on multiple operational cylinders.

Yet its market cap hovers around just $5 million. Shares are trading at roughly $0.50.

That valuation gap isn’t just striking—it’s absurd.

Why does it exist? Likely because institutional capital can’t build a meaningful stake in Brenmiller without taking control. With only around 12 million shares outstanding, there’s simply not enough float to create the kind of returns they need at scale. That leaves the opportunity wide open for retail investors. Based on the price-to-projects-to-pipeline ratio, Brenmiller stock may be one of the most glaring disconnects on the NASDAQ.

Earning The Spotlight

Getting attention hasn’t been easy. Rondo is the poster child for buzz—with bold vision major names like Bill Gates and other big hitters behind it. While Rondo’s future may pan out, the present still belongs to Brenmiller.

Consider this: Brenmiller’s bGen™ system has already been validated across Europe, the Middle East, and the Americas. It stores industrial-scale heat using crushed rocks and discharges it on demand—24/7/365—for steam, hot air, or process heat. Current clients include Tempo Beverage, ENEL, Entelio, Green Enesys, and Viridi. Plenty more are lined up.

In other words, this isn’t a “build it and they will come” story. Brenmiller built it. And customers came.

Their latest validation? The European Hydrogen Bank’s €25 million award to the SolWinHy Cádiz green methanol project in Spain. Of that, €7 million is earmarked specifically for Brenmiller’s bGen™ units. The project will run fully off-grid, powered by solar, wind, green hydrogen, and stabilized by Brenmiller’s storage.

From Pipeline to Inflection

Beyond Spain, Brenmiller has reported a commercial pipeline exceeding $500 million, roughly $200 million of that in Europe. These aren’t abstract conversations—they’re real deals, many in engineering phases. The Tempo Beverage deployment in Israel is a key near-term milestone. It’s another high-profile proof point of TES delivering cost savings, emission reductions, and reliability in real-world industry. Most importantly, from an investor’s perspective— a near-term value driver.

Now zoom out.

As reported by CNBC on May 27, Europe is reversing its resistance to nuclear energy. Countries like Germany, Denmark, and Spain are re-integrating nuclear into their energy mix. The U.S. is following suit. New executive orders from the Trump administration have fast-tracked small modular reactors (SMRs) and cleared red tape for nuclear infrastructure.

But nuclear has a known flaw—it doesn’t scale output with demand. These plants are built for baseload generation. That’s where TES becomes indispensable.

Brenmiller’s bGen™ fills this gap. It allows nuclear facilities to operate at full capacity, storing surplus energy as heat and then releasing it to meet peak demand or support industrial users. It’s the critical link between baseload generation and variable grid needs.

Even better—Brenmiller already has nuclear-adjacent experience through its partnership with Enel, Europe’s largest utility by customer count and a global renewables pioneer. That gives Brenmiller a first-mover advantage as the next wave of nuclear infrastructure takes off.

The Market’s Backwards Logic

So here we are. Rondo Energy—minimal revenues, few deployments, and a speculative roadmap—gets a $500 million+ valuation. Meanwhile, Brenmiller, with sovereign-funded projects, multi-continent operations, and verified industrial customers, is worth just $5 million?

Markets aren’t always rational in the short term. That’s why prices swing. However, in the long term, execution and fundamentals prevail. And when they do, it’s the early believers—not the latecomers—who benefit most.

Still Hiding in Plain Sight

This isn’t our first write-up on Brenmiller. And it won’t be our last. Because in a sector drowning in hype, one company is already delivering.

It works. We are simply working to level the playing field. Yes, retail investors can capitalize on TES and potentially reap a substantial return on their investment. Perhaps not the billions in return like Gates, et al., but still plenty to change a portfolio.

The infrastructure is real. Revenues are materializing. The pipeline is growing. And the catalysts—like Tempo and SolWinHy—are within sight. Most importantly, Brenmiller’s core tech solves one of the most urgent global energy challenges: storing and dispatching heat sustainably.

Yes, Brenmiller Energy is still flying under the radar. But that’s changing. Markets are waking up to the true value of a company that isn’t theorizing change—it’s driving it. If speculative favorites stumble or fail to meet expectations, Brenmiller could become the TES sector’s re-rated frontrunner overnight.

And right now, it’s still hiding in plain sight. Based on headlines, it won’t much longer.

 

Disclaimers and Disclosures:Hawk Point Media Group, LLC. (HPM) has not been compensated to produce and distribute this content. It should be expressly understood that HPM is not operated by a licensed broker, a dealer, or a registered investment adviser. It should also be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. HPM reports/releases are commercial advertisements and are for general information purposes ONLY. The information made available by HPM is not intended to be, nor does it constitute, investment advice or recommendations. The contributors do NOT buy and sell securities covered before or after any particular article, report and/or publication. HPM holds ZERO shares in Brenmiller Energy Ltd. Always do your own due diligence prior to investing in any publicly traded company. While HPM has not been compensated for creating and syndicating this content, HPM discloses having a prior services agreement with the company, and third parties, that expired in April 2025 and 2024, respectively. HPM is a digital marketing and consulting company. Therefore, it is possible that HPM will be retained in the future to create and syndicate digital content for Brenmiller Energy. Accordingly, while fact-based and sourced, our content may portray featured companies in only the most favorable way. A complete disclosure for all services provided and compensated for is linked below. Forward-Looking Statements: This article contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. Statements that are not statements of historical fact may be deemed to be forward-looking statements. The forward-looking statements contained or implied in this article are subject to other risks and uncertainties, many of which are beyond the control of the Company featured or HPM. Hawk Point Media Group, Llc. undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law. For Hawk Point Media Group Llc’s full disclaimer and disclosure statement, click HERE.

Media Contact
Company Name: Hawk Point Media
Contact Person: Editorial Dept.
Email: info@hawkpointmedia.com
Country: United States
Website: https://hawkpointmedia.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Brenmiller Energy: A Thermal Energy Storage Play Hiding in Plain Sight ($BNRG)

Kiwi Imprints Expands Custom Branding Capabilities in Plano with New Equipment and Design Services

Kiwi Imprints Expands Custom Branding Capabilities in Plano with New Equipment and Design Services
Kiwi Imprints, a leader in personalized branding and promotional products, has announced the expansion of its operations in Plano, Texas. The company has invested in state-of-the-art production equipment and expanded its design team to better serve local businesses, schools, and organizations seeking high-quality custom signage and apparel.

With the growing demand for unique branding materials in the North Texas market, Kiwi Imprints is positioning itself as a comprehensive solution for clients who need fast, professional, and affordable customization. The business specializes in various services, including apparel printing, vinyl signage, embroidery, and business branding packages tailored to startups and established companies.

This latest expansion includes upgraded technology for creating signs Plano businesses use to stand out in highly competitive environments. The improvements allow Kiwi Imprints to produce large-scale outdoor and indoor signage with greater speed and precision, enhancing visibility for storefronts, events, and public-facing campaigns.

Additionally, the company is expanding its textile division to meet the increased interest in embroidery, Plano schools and corporate teams rely on for logos, uniforms, and spirit wear. By integrating newer machines and expanding design consultations, Kiwi Imprints is improving quality while reducing turnaround times.

In response to a growing need for storefront visibility and promotional messaging, Kiwi Imprints is also broadening its services for window signs Plano retailers are increasingly using for seasonal promotions, sales events, and branding. The company offers customized solutions for all window sizes and materials, including perforated vinyl and UV-resistant film.

Founded on the principle of local creativity and professional service, Kiwi Imprints continues to serve as a trusted partner for businesses in Plano and surrounding areas. The company’s expanded services underscore its commitment to innovation, quality, and local economic growth.

For more information about their services and the company, please contact (972) 423-2730 or visit their website at https://kiwiimprints.com/

Media Contact
Company Name: Kiwi Imprints (Artistic Textile) – Best Signs, TShirts, Embroidery and more
Contact Person: Javed Memon
Email: Send Email
Phone: (972) 423-2730
Address:1111 Summit Ave STE 7
City: Plano
State: TX 75074
Country: United States
Website: https://kiwiimprints.com/

EnJoyPay Featured at Money20/20 Asia Bangkok

From April 22 to 24, EnJoyPay showcased at Asia’s top fintech conference Money20/20 Asia (booth K20), presenting global payment solutions to explore Southeast Asian market opportunities with global game developers, financial institutions, and cross-border ecosystem partners.

On-site booth snapshot

The EnJoyPay team engaged in cooperation discussions with financial companies, payment channels, and game developers from around the world, jointly exploring player payment experience optimization and global compliance deployment.

Currently, EnJoyPay holds Hong Kong MSO, Canada MSB, US MSB licenses, and PCI certification qualifications, offering stable compliance credentials and professional risk control. Building on this foundation, EnJoyPay provides over 500 payment solutions globally, covering more than 80 major countries and regions, supporting over 30 local languages, with advantages in regions including Japan, Korea, Southeast Asia, Latin America, and more. The aim is to maximize the global value of gaming products. By expanding regional influence, EnJoyPay assists overseas gaming companies in strengthening local payment deployment depth, increasing transaction volume and revenue, while helping reduce comprehensive channel costs to achieve commercial success in global markets.

Partnering with EnJoyPay to Unlock New Potential in Southeast Asian Game Globalization

EnJoyPay’s payment channels in Southeast Asia have been fully established and continue to be improved. With a profound understanding and rich experience in Southeast Asian local payment markets, EnJoyPay provides game companies with seamlessly integrated payment systems, ensuring efficient and secure payment services. In addition to technical support, EnJoyPay also offers market insights and operational advice to partners, comprehensively assisting enterprises in deepening their presence in Southeast Asian markets.

At Money20/20 Asia, a global stage, EnJoyPay identified new opportunities for digital content to go global. The company looks forward to working with more partners to explore blue ocean opportunities in the Southeast Asian gaming market. EnJoyPay will continuously optimize payment solutions, supporting Chinese gaming companies’ development from commercial monetization to user operations.

June is Coming: EnJoyPay Invites Global Gaming Partners to Money20/20 Europe in the Netherlands

Money20/20 is a top global fintech conference, with its European event known as the “weathervane of payment innovation,” gathering international giants like Visa and more than 5,000 financial institutions, focusing on cross-border payments, open banking, and other core topics. The 2025 exhibition will be held at the RAI Amsterdam Convention Centre, injecting global resources into the European market.

From June 3 to 5 in Amsterdam, Netherlands, at Booth K16 – EnJoyPay welcomes global gaming partners to visit and exchange ideas.

European Market Scale: Newzoo data shows that the European gaming market will exceed €36 billion by 2025, with Germany, the UK, and France contributing over 60% share.

Player Paying Power: European players’ ARPU reaches €45 (global average €28), with credit card payments accounting for over 65%.

Compliance Threshold: EU PSD2 regulations mandate payment institutions to implement SCA (Strong Customer Authentication). EnJoyPay partners with European licensed entities to help companies quickly achieve compliance.

As a compliance expert in the field of game cross-border payments, and based on Hong Kong MSO, Canada MSB, US MSB licenses, and PCI DSS certification, EnJoyPay provides gaming companies with the following core services:

Global Payment Network: Supporting international card organizations like Visa and Mastercard, covering mainstream payment methods for European and American players, increasing transaction success rates by 25%.

Compliance Risk Control System: PCI DSS-certified data encryption technology ensures zero leakage of player payment information, meeting EU GDPR and other privacy regulations.

Localized Operation Solutions: One-on-one consultation, customized rate plans, and practical strategies on how to increase European players’ payment success rates by 25%.

About EnJoyPay

EnJoyPay is a global game local payment expert, providing professional and intelligent global payment solutions for overseas game and application developers, helping them quickly and safely penetrate global markets. It has now become a global payment partner for many overseas developers.

EnJoyPay has offices in five core cities: Beijing, Shanghai, Hangzhou, Guangzhou, and Hong Kong. In Europe, the company also has a professional and diverse employee team, experienced and highly compliant. EnJoyPay deeply invests resources and establishes multiple touchpoints, committed to creating excellent business and delivering value to customers.

EnJoyPay actively participates in internationally renowned exhibitions, including the Singapore FinTech Festival and Tokyo Game Show, comprehensively covering the market, fully demonstrating business advantages, and effectively enhancing the brand’s recognition and influence among overseas user groups.

LinkedIn: EnJoyPay

WeChat: enjoykjzs

Media Contact
Company Name: EnJoyPay
Contact Person: Liu Shuiyoulan
Email: Send Email
Country: Thailand
Website: https://enjoypayment.com/

Milford Precision Tile Rebuilds Failing Shower in Darien, CT with Industry-Leading Waterproofing System

Milford Precision Tile Rebuilds Failing Shower in Darien, CT with Industry-Leading Waterproofing System

Shower Tile Installation Failure
When a homeowner in Darien, CT noticed water stains forming on their dining room ceiling, it became clear that their upstairs shower was leaking — and the damage was getting worse.

Milford, CT – When a homeowner in Darien, CT noticed water stains forming on their dining room ceiling, it became clear that their upstairs shower was leaking — and the damage was getting worse. They turned to Milford Precision Tile, a local tile installation specialist, for help. The result: a full tear-out and expert rebuild using the Schluter® waterproof shower installation system, giving the homeowner peace of mind and a brand-new, modern shower built to last.

According to Milford Precision Tile, there are no shortcuts or “quick fixes” when it comes to water leaks behind tile. “Once moisture gets behind the surface, it compromises the entire system,” said the company’s owner. “You have to remove everything and rebuild it properly — otherwise the problem will just keep coming back.”

The original shower, installed by a different contractor, had no proper waterproofing behind the tile. This allowed water to seep into the framing and subfloor, eventually leaking into the ceiling below. Milford Precision Tile’s team removed the entire enclosure down to the studs, repaired the damage, and rebuilt the shower using a complete Schluter® waterproofing system — widely considered the gold standard in the tile industry.

Along with waterproofing, the rebuild included updated ceramic tile shower installation, upgraded plumbing fixtures, mold-resistant grout, and professional sealing. The result was a leak-proof, visually stunning shower that brought both relief and style to the homeowner.

Milford Precision Tile has over 20 years of experience specializing in custom tile showers, backsplashes, and floor installations across Milford, Darien, and the surrounding Connecticut shoreline communities.

“We don’t believe in band-aid solutions. If a shower is failing, we give our clients a clean slate and build something they can trust for decades.”

The company is currently offering free consultations for homeowners concerned about shower leaks, cracked tiles, or aging bathrooms.

To schedule a consultation, call (203) 479-0140‬.

About Milford Precision Tile:

Milford Precision Tile is a locally owned tile installation company specializing in high-quality, long-lasting tile work for showers, kitchens, and floors. Known for expert craftsmanship and precision waterproofing, the company serves homeowners throughout Milford, CT and surrounding areas.

Media Contact
Company Name: Milford Precision Tile
Contact Person: Dan
Email: Send Email
Phone: (203) 479-0140?
City: Milford
State: Connecticut
Country: United States
Website: www.milfordprecisiontile.com/ceramic-tile-shower-installation-darien-ct/

Affordable & Professional Window & Gutter Cleaning Powerwashing Services Delivers Superior Exterior Cleaning Solutions in Freehold, NJ

Affordable & Professional Window & Gutter Cleaning Powerwashing Services Delivers Superior Exterior Cleaning Solutions in Freehold, NJ
Affordable & Professional Window & Gutter Cleaning Powerwashing Services continues to set the standard for exceptional exterior cleaning services in the region. With a reputation built on reliability and attention to detail, the company offers comprehensive solutions for both residential and commercial properties throughout Monmouth County and beyond.

Known for expert pressure washing and meticulous care of all exterior surfaces, Affordable & Professional Window & Gutter Cleaning Powerwashing Services specializes in transforming properties through advanced cleaning techniques. Homeowners and business owners seeking Freehold Pressure Washing services can rely on this locally trusted provider for spotless and lasting results.

The company’s technicians use top-grade equipment and eco-friendly products to ensure effective cleaning that enhances curb appeal while preserving property value. Services include siding, concrete, patios, decks, driveways, and roof cleaning. Those looking for Pressure Washing Freehold services benefit from a well-trained team that understands the specific challenges of the local environment, including mold, mildew, and seasonal debris.

With a commitment to customer satisfaction and high-quality workmanship, Affordable & Professional Window & Gutter Cleaning Powerwashing Services has become the go-to choice forPressure Washing in Freehold. The company also offers specialized services such as window cleaning, gutter maintenance, and soft washing for delicate surfaces, ensuring comprehensive care for every property.

Serving the Freehold community with pride and professionalism, Affordable & Professional Window & Gutter Cleaning Powerwashing Services invites property managers, real estate professionals, and homeowners to discover the difference that true exterior cleaning expertise can make.

Media Contact
Company Name: Affordable & Professional Window & Gutter Cleaning Powerwashing Services
Contact Person: John Oshinski
Email: Send Email
Phone: (732) 462-0462
Address:18 Willow Brook Rd
City: Freehold
State: NJ 07728
Country: United States
Website: https://www.affordable-and-professional.com/

Desert Kids Dental Continues to Provide HealthyStart® Program for Long-Term Pediatric Wellness in Las Vegas

“Dr. Sandra Thompson at Desert Kids Dental in Las Vegas, NV.”
Desert Kids Dental, a trusted kids dentist serving Las Vegas communities has long offered the HealthyStart® program to support children’s oral development and overall health.

Desert Kids Dental, a trusted kids dentist serving Las Vegas communities including Providence, Skye Canyon, Summerlin, and Centennial Hills, has long offered the HealthyStart® program to support children’s oral development and overall health. Under the experienced care of Dr. Sandra Thompson, this non-invasive treatment continues to help children achieve better sleep, healthier airways, and properly aligned smiles—all without braces or surgery.

What Is the HealthyStart® Program?

The HealthyStart® system is a series of soft, comfortable oral appliances designed to address sleep-disordered breathing (SDB) in children. Worn primarily at night, the appliance gently guides the growth of the jaws, expands the airway, and aligns teeth as they develop. This early intervention can prevent the need for future orthodontic treatment while also improving sleep and behavior.

Dr. Sandra Thompson and her team have successfully used HealthyStart® to support children struggling with mouth breathing, snoring, grinding, bedwetting, or signs of ADHD—all of which are often linked to undiagnosed sleep issues. By identifying these concerns early, Desert Kids Dental provides families with effective tools to promote both oral health and overall well-being.

Why Families in Las Vegas Choose HealthyStart®

  • Non-Invasive & Drug-Free: No surgery or medications—just gentle guidance through custom-fit oral appliances.
  • Better Sleep = Better Behavior: Improved breathing at night can lead to better focus, mood, and learning during the day.
  • Supports Natural Tooth Alignment: Guides teeth into their ideal position during growth, often eliminating the need for braces.
  • Addresses the Root Cause: Focuses on airway development and jaw positioning, not just symptoms.


Leading Care from a Dedicated Kids Dentist

Dr. Sandra Thompson is known throughout Las Vegas as a compassionate, knowledgeable kids dentist who focuses on preventive care and whole-child wellness. Her commitment to offering advanced solutions like HealthyStart® reflects the clinic’s broader mission—to give every child the healthiest start possible.

At Desert Kids Dental, families find a supportive environment where concerns are heard, children feel safe, and early intervention is always the goal. Whether it’s a routine checkup or a comprehensive evaluation for airway health, Dr. Thompson ensures each treatment plan is tailored to the child’s needs.

Serving Providence, Skye Canyon, Summerlin, and Centennial Hills

Located conveniently in Northwest Las Vegas, Desert Kids Dental continues to be a trusted choice for families across Providence, Skye Canyon, Summerlin, and Centennial Hills. Parents looking for a reliable kids dentist who offers innovative, child-friendly solutions find peace of mind knowing their child’s growth and development are supported at every stage.

Desert Kids Dental also offers a wide range of pediatric dental services—from cleanings and fluoride treatments to sealants and restorative care. The integration of the HealthyStart® program reflects the clinic’s belief in treating the root causes of dental and developmental concerns, not just the symptoms.

Book Your Child’s HealthyStart® Evaluation

If your child shows signs of restless sleep, difficulty breathing at night, or crowded teeth, it may be time to schedule a consultation. Desert Kids Dental offers comprehensive evaluations to determine if the HealthyStart® program is right for your child.

For families searching for a trusted kids dentist in Las Vegas, Desert Kids Dental remains a leading provider of expert pediatric care and early developmental support.

Media Contact
Company Name: Desert Kids Dental
Contact Person: Media Relations
Email: Send Email
Phone: 702-660-7099
Address:9859 W Deer Springs Way STE 110
City: Las Vegas
State: NV 89149
Country: United States
Website: https://www.desertkidsdental.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Desert Kids Dental Continues to Provide HealthyStart® Program for Long-Term Pediatric Wellness in Las Vegas

PAWPANG Launches Upgraded Dog Diaper Liners with Enhanced Absorbency and Leak-Proof Fit

PAWPANG, the premium pet hygiene brand known for its leak-proof dog diaper liners, has announced a major product upgrade following a full brand refresh. The new and improved booster pads for dogs are now available, featuring enhanced absorbency, better fit, and a cleaner, more premium brand experience.

Upgraded Absorbency with Japanese Core Materials

The biggest innovation? Each liner now absorbs 1–2 fl oz more liquid per size, thanks to an advanced Japanese-made absorbent core. Designed for use with reusable dog diapers, male wraps, and female dog diapers, the liners instantly lock in urine and help keep your home dry. No more unexpected leaks on your floors, furniture, or bedding.

Secure Fit, Even for Active Dogs

PAWPANG also upgraded its adhesive system, going from 4 to 5 adhesive strips, improving the stay-put grip even for wiggly, playful pups. Whether you’re using them with belly bands or full-coverage reusable diapers, the liners now offer better performance with less shifting and bunching.

Smarter Embossing, Cleaner Branding

In addition to performance, PAWPANG’s new liners now feature a custom-designed signature embossing pattern, replacing the generic texture seen in most brands. The new embossing ensures better fluid distribution while visually reinforcing the brand’s premium identity.

To match this evolution, PAWPANG also revealed a full brand redesign, including new packaging, a refreshed brand mascot, and color-coded size indicators for easier selection.

Quick Summary of What’s New:

  • +1–2 fl oz more absorbency per liner (by size)
  • Upgraded from 4 to 5 adhesive strips for better fit
  • New signature PAWPANG embossing pattern for leak control
  • Complete brand refresh: packaging, character, and tone

Designed for Real-Life Messes

Perfect for senior dogs, UTI (Urinary Tract Infection), incontinence, dogs in heat, indoor markers, or mobility issue, PAWPANG dog diaper booster pads work seamlessly with reusable and disposable dog diapers. They’re also a popular insert for male belly bands, helping pet parents reduce full diaper changes, lower laundry loads, and improve everyday hygiene.

“It’s the small improvements that make the biggest difference,” says the PAWPANG team. “We listened to what our customers were saying especially about absorption and adhesive performance. Hence, we upgraded exactly where it mattered most, without changing what they already loved.”

The new liners are now available on Amazon and PAWPANG brand website.

Media Contact
Company Name: PAWPANG
Contact Person: Theo Lee
Email: Send Email
Country: Korea
Website: https://www.pawpang.com/

Uterine Leiomyosarcoma Pipeline Appears Robust With 5+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

DelveInsight’s, “Uterine Leiomyosarcoma Pipeline Insight 2025” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Uterine Leiomyosarcoma pipeline landscape. It covers the Uterine Leiomyosarcoma Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Uterine Leiomyosarcoma Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Discover the latest drugs and treatment options in the Uterine Leiomyosarcoma Pipeline. Dive into DelveInsight’s comprehensive report today! @ Uterine Leiomyosarcoma Pipeline Outlook

Key Takeaways from the Uterine Leiomyosarcoma Pipeline Report

  • In March 2025, UNICANCER announced a phase II trial designed to demonstrate whether adding 4 cycles of post-operative chemotherapy improves relapse-free survival as compared with follow-up (standard management) in patients with resected FIGO stage I uterine leiomyosarcoma, considered at high-risk according to CINSARC NanoCind® signature.
  • DelveInsight’s Uterine Leiomyosarcoma Pipeline report depicts a robust space with 5+ active players working to develop 5+ pipeline therapies for Uterine Leiomyosarcoma treatment.
  • The leading Uterine Leiomyosarcoma Companies such as Novartis, PharmMar, and others.
  • Promising Uterine Leiomyosarcoma Pipeline Therapies such as Doxorubicin, Trabectedin, gemcitabine + docetaxel, letrozole, Pazopanib, Carboplatin and others.

Stay ahead with the most recent pipeline outlook for Uterine Leiomyosarcoma. Get insights into clinical trials, emerging therapies, and leading companies with DelveInsight @ Uterine Leiomyosarcoma Treatment Drugs

Uterine Leiomyosarcoma Emerging Drugs Profile

  • Trabectedin: PharmMar

Yondelis® (trabectedin) is a novel, synthetically produced antitumor agent originally isolated from Ecteinascidia turbinata, a type of sea squirt. Yondelis® exerts its anticancer effects primarily by inhibiting active transcription, a type of gene expression on which proliferating cancer cells are particularly dependent.

  • Letrozole: Novartis

Letrozole is a non-steroidal type II aromatase inhibitor. It blocks the active site, and therefore the electron transfer chain of CYP19A1. This competitive inhibition prevents the conversion of androgens to estrogen. This action leads to a reduction in uterine weight and elevated leuteinizing hormone.8 In postmenopausal women, the action of aromatase is responsible for the majority of estrogen production. With reduced availability of estrogen, estrogen-dependant tumors regress. Third generation aromatase inhibitors do not significantly affect cortisol, aldosterone, and thyroxine levels. Currently, in phase II of clinical trials.

The Uterine Leiomyosarcoma Pipeline Report Provides Insights into

 

  • The report provides detailed insights about companies that are developing therapies for the treatment of Uterine Leiomyosarcoma with aggregate therapies developed by each company for the same.
  • It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Uterine Leiomyosarcoma Treatment.
  • Uterine Leiomyosarcoma Companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
  • Uterine Leiomyosarcoma Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
  • Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Uterine Leiomyosarcoma market

Explore groundbreaking therapies and clinical trials in the Uterine Leiomyosarcoma Marketed and Pipeline Drugs. Access DelveInsight’s detailed report now! @ New Uterine Leiomyosarcoma Drugs

Uterine Leiomyosarcoma Companies

Novartis, PharmMar, and others.

Uterine Leiomyosarcoma pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as

  • Subcutaneous
  • Intravenous
  • Oral
  • Intramuscular
  • Molecule Type

Uterine Leiomyosarcoma Products have been categorized under various Molecule types such as

  • Small molecules
  • Natural metabolites
  • Monoclonal antibodies
  • Product Type

Unveil the future of Uterine Leiomyosarcoma Treatment. Learn about new drugs, pipeline developments, and key companies with DelveInsight’s expert analysis @ Uterine Leiomyosarcoma Market Drivers and Barriers

Scope of the Uterine Leiomyosarcoma Pipeline Report

  • Coverage- Global
  • Uterine Leiomyosarcoma Companies- Novartis, PharmMar, and others.
  • Uterine Leiomyosarcoma Pipeline Therapies- Doxorubicin, Trabectedin, gemcitabine + docetaxel, letrozole, Pazopanib, Carboplatin and others.
  • Uterine Leiomyosarcoma Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
  • Uterine Leiomyosarcoma Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

Get the latest on Uterine Leiomyosarcoma Therapies and clinical trials. Download DelveInsight’s in-depth pipeline report today! @ Uterine Leiomyosarcoma Companies, Key Products and Unmet Needs

Table of Contents

  1. Introduction
  2. Executive Summary
  3. Uterine Leiomyosarcoma: Overview
  4. Pipeline Therapeutics
  5. Therapeutic Assessment
  6. Uterine Leiomyosarcoma – DelveInsight’s Analytical Perspective
  7. In-depth Commercial Assessment
  8. Uterine Leiomyosarcoma Collaboration Deals
  9. Late Stage Products (Phase III)
  10. Drug profiles in the detailed report…..
  11. Mid Stage Products (Phase II)
  12. Letrozole: Novartis
  13. Drug profiles in the detailed report…..
  14. Pre-clinical and Discovery Stage Products
  15. Drug profiles in the detailed report…..
  16. Inactive Products
  17. Uterine Leiomyosarcoma Key Companies
  18. Uterine Leiomyosarcoma Key Products
  19. Uterine Leiomyosarcoma- Unmet Needs
  20. Uterine Leiomyosarcoma- Market Drivers and Barriers
  21. Uterine Leiomyosarcoma- Future Perspectives and Conclusion
  22. Uterine Leiomyosarcoma Analyst Views
  23. Uterine Leiomyosarcoma Key Companies
  24. Appendix

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/uterine-leiomyosarcoma-pipeline-insight

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Uterine Leiomyosarcoma Pipeline Appears Robust With 5+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

Meningioma Pipeline Appears Robust With 5+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

DelveInsight’s, “Meningioma Pipeline Insight 2025” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Meningioma pipeline landscape. It covers the Meningioma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Meningioma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Discover the latest drugs and treatment options in the Meningioma Pipeline. Dive into DelveInsight’s comprehensive report today! @ Meningioma Pipeline Outlook

Key Takeaways from the Meningioma Pipeline Report

  • In May 2025, European Organisation for Research and Treatment of Cancer – EORTC conducted a LUMEN-1 trial will investigate in a prospective randomized trial the efficacy of the precision medicine “theranostic” concept of combining diagnostic patient selection using PET-based molecular imaging and target-specific therapeutic intervention using a systemically administered radioligand.
  • In May 2025, Baptist Health South Florida announced a phase II Study of Cabozantinib for Patients with Recurrent or Progressive Meningioma.
  • DelveInsight’s Meningioma Pipeline report depicts a robust space with 5+ active players working to develop 5+ pipeline therapies for Meningioma treatment.
  • The leading Meningioma Companies such as NX Development Corp., Clarity Pharmaceutical Ltd., Bristol-Myers Squibb, Biosynthema Inc., and others.
  • Promising Meningioma Pipeline Therapies such as Nivolumab, Cabozantinib, Abemaciclib, SOM230C, Bevacizumab, 177Lu-DOTATATE, Pembrolizumab and others.

Stay ahead with the most recent pipeline outlook for Meningioma. Get insights into clinical trials, emerging therapies, and leading companies with DelveInsight @ Meningioma Treatment Drugs

Meningioma Emerging Drugs Profile

  • Gleolan: NX Devolopment Corp

NX development corp.’s drug, Gleolan also known as Aminolevulinic acid is an orally administered small molecule in development for the treatment and real time detection of meningioma. Gleolan is a prodrug that is metabolized intracellularly to form the fluorescent molecule Protoporphyrin IX (PpIX). The exogenous application of ALA leads to a highly selective accumulation of PpIX in tumor cells. Following excitation with blue light. It is a photosensitizer molecule which can utilize the energy to induce photochemical reactions to produce lethal toxic agents; ultimately results in cell death and tissue destruction.

  • Nivolumab: Bristol-Myers Squibb

Bristol-Myers Squibb “breakthrough” drug nivolumab is currently being evaluated for the treatment of Meningioma and has demonstrated good safety and efficacy profile in phase II trials. Nivolumab is a human immunoglobin (IgG4) monoclonal antibody that binds to the PD-1 receptor and blocks the interaction with PD-L1 and PD-L2, releasing anti-tumor response.

The Meningioma Pipeline Report Provides Insights into

  • The report provides detailed insights about companies that are developing therapies for the treatment of Meningioma with aggregate therapies developed by each company for the same.
  • It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Meningioma Treatment.
  • Meningioma Companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
  • Meningioma Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
  • Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Meningioma market

Explore groundbreaking therapies and clinical trials in the Meningioma Marketed and Pipeline Drugs. Access DelveInsight’s detailed report now! @ New Meningioma Drugs

Meningioma Companies

NX Development Corp., Clarity Pharmaceutical Ltd., Bristol-Myers Squibb, Biosynthema Inc., and others.

Meningioma Pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as

  • Subcutaneous
  • Intravenous
  • Oral
  • Intramuscular
  • Molecule Type

Meningioma Products have been categorized under various Molecule types such as

  • Small molecules
  • Natural metabolites
  • Monoclonal antibodies
  • Product Type

Unveil the future of Meningioma Treatment. Learn about new drugs, pipeline developments, and key companies with DelveInsight’s expert analysis @ Meningioma Market Drivers and Barriers

Scope of the Meningioma Pipeline Report

  • Coverage- Global
  • Meningioma Companies- NX Development Corp., Clarity Pharmaceutical Ltd., Bristol-Myers Squibb, Biosynthema Inc., and others.
  • Meningioma Pipeline Therapies- Nivolumab, Cabozantinib, Abemaciclib, SOM230C, Bevacizumab, 177Lu-DOTATATE, Pembrolizumab and others.
  • Meningioma Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
  • Meningioma Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III

Get the latest on Meningioma Therapies and clinical trials. Download DelveInsight’s in-depth pipeline report today! @ Meningioma Companies, Key Products and Unmet Needs

Table of Contents

  1. Introduction
  2. Executive Summary
  3. Meningioma: Overview
  4. Pipeline Therapeutics
  5. Therapeutic Assessment
  6. Meningioma – DelveInsight’s Analytical Perspective
  7. In-depth Commercial Assessment
  8. Meningioma Collaboration Deals
  9. Late Stage Products (Phase III)
  10. Gleolan: Nx Development Corp.
  11. Drug profiles in the detailed report…..
  12. Mid Stage Products (Phase II)
  13. Nivolumab: Bristol-Myers Squibb
  14. Drug profiles in the detailed report…..
  15. Pre-clinical and Discovery Stage Products
  16. Drug profiles in the detailed report…..
  17. Inactive Products
  18. Meningioma Key Companies
  19. Meningioma Key Products
  20. Meningioma- Unmet Needs
  21. Meningioma- Market Drivers and Barriers
  22. Meningioma- Future Perspectives and Conclusion
  23. Meningioma Analyst Views
  24. Meningioma Key Companies
  25. Appendix

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/meningioma-pipeline-insight

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Meningioma Pipeline Appears Robust With 5+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight